Hospital Carlos III-ko ikertzaileekin lankidetzan egindako argitalpenak (101)

2021

  1. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

2020

  1. Imported cysticercosis in Spain: A retrospective case series from the +REDIVI Collaborative Network

    Travel Medicine and Infectious Disease, Vol. 37

  2. Latent and active tuberculosis infections in migrants and travellers: A retrospective analysis from the Spanish +REDIVI collaborative network

    Travel Medicine and Infectious Disease, Vol. 36

2019

  1. A new variant (c.1A>G)in LDLRAP1 causing autosomal recessive hypercholesterolemia: Characterization of the defect and response to PCSK9 inhibition

    Atherosclerosis, Vol. 284, pp. 223-229

  2. Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi network

    Travel Medicine and Infectious Disease, Vol. 29, pp. 51-57

  3. Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia

    Human Mutation, Vol. 40, Núm. 8, pp. 1181-1190

  4. Standards for global cardiovascular risk management arteriosclerosis

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 1-43

2018

  1. COSMIC project: Consensus on the objectives of the metabolic syndrome in clinic

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11, pp. 683-697

  2. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

2017

  1. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

  2. Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study

    PLoS ONE, Vol. 12, Núm. 10

2016

  1. Fármacos hipolipemiantes y PCSK9

    Clinica e Investigacion en Arteriosclerosis, Vol. 28, pp. 9-13

  2. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596

  3. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

  4. Short communication: p21/CDKN1A expression shows broad interindividual diversity in a subset of HIV-1 elite controllers

    AIDS Research and Human Retroviruses, Vol. 32, Núm. 3, pp. 232-236

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  2. Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 1, pp. 46-54

  3. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis

    Nature Communications, Vol. 6

  4. Normal reference values of left ventricular strain using three-dimensional speckle tracking echocardiography: Results from amulticentre study

    European Heart Journal Cardiovascular Imaging, Vol. 16, Núm. 4, pp. 410-416

  5. Novedades cardiovasculares 2013/2014

    Revista Clinica Espanola, Vol. 215, Núm. 1, pp. 33-42